What's driving the Cancer Gene Therapy Market trends? Sibiono Genetech, Shanghai Sunway Biotech Co., LTD, Human Stem Cell Institute, Altor Bioscience Corporation, Amgen, BioCancell, Aduro Biotech, OncoGeneX, Celsion, GlobeImmune, Inc, New Link Geneticsm,

A collective analysis on ‘Cancer Gene Therapy market’ by Market Study Report, LLC, offers an exhaustive study based on current trends influencing this vertical throughout assorted geographies. Key information regarding market size, market share, statistics, application, and revenue are compiled in the research to develop an ensemble prediction. In addition, this research offers a detailed competitive analysis focusing on business outlook emphasizing expansion strategies accepted by market majors.

Cancer Gene Therapy Market size is expected to exceed USD 4.3 billion by 2024; as per a new research report by. Globally, rising cancer prevalence will increase demand for gene therapy as the effective personalized treatment choice. According to WHO, cancer incidence is projected to rise by 50% to reach 15 million by the end of this decade. This alarming increase in number of patients necessitates this as a potential treatment approach addressing the growing global burden of the disease.

Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/467801?utm_source=openpr.com&utm_medium=Abhijeet

Key players include SiBiono, Altor Bioscience Corporation, Shanghai Sunway Biotech company limited, Amgen, BioCancell, OncoGeneX, Aduro Biotech, GlobeImmune, Inc., New Link Genetics., ZioPharm Oncology, MolMed, GENELUX, Gradalis, MultiVir.

Increased adoption of emerging genomic technologies such as NGS and high density micro array coupled with favorable government initiatives will fuel global cancer gene therapy market size. For instance, CDC supports nationwide screening programs for control of breast, cervical and colorectal cancer among low-income women with little or no health insurance. However, high cost of development lack of reimbursement and regulatory processes will restrain industry growth.

Growing number of clinical trials and availability of wide range of genes and vectors used in these trials will enable emergence of new treatment modalities to help make cancer a manageable disease. By the end of 2012, the number of clinical trials crossed 1,800 worldwide.

Adenoviral vector remains as the most common oncology application due to its competent nuclear mechanism and low pathogenicity. It is widely used in replacement approaches, suicide and gene-based immunotherapy, and syndicate with chemotherapy and is anticipated to grow at 20% CAGR.

Retroviral vector-mediated gene transfer dominated the development by enabling the conversion of single stranded RNA into a double stranded DNA molecule, which steadily integrates into the target cell genome. These vectors are used to permanently modify the host cell nuclear genome and will register a robust growth of over 20%.

U.S. led the industry owing to increased R&D funding and other government initiatives. Growing number of biotech companies are engaging in R&D and clinical trials of gene therapy products. Increased demand for DNA vaccines and increasing interest of venture capitalists to invest in commercialization of gene therapies will trigger industry expansion.

China cancer gene therapy market size attributed to over 35% APAC revenue in 2015. With the launch of Gendicine and increasing healthcare expenditure and robust R&D facilities will enable industry growth.

Key insights from the report include:

U.S. cancer gene therapy market share accounted for over 95% regional revenue in 2015, with market size of USD 235 million and a forecast to grow at 20.9% CAGR.
UK was over USD 92.0 million in 2015, and will grow at 20.8% CAGR owing to increasing incidence of cancer and adoption of advanced treatment methods.China market size was valued at USD 99.6 million in 2015 and growth expectations of 21% CAGR over the forecast years.

The industry is highly fragmented and is dominated by several small biotech firms collectively accounting for over 80% of cancer gene therapy market pipeline. Major growth strategies adopted by these small firms include, technology transfer, licensing and commercialization deals, strategic collaborations and mergers and acquisitions to retain their industry position.

Global Market Insights has segmented the cancer gene therapy industry on the basis of therapy type, and region

Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/467801?utm_source=openpr.com&utm_medium=Abhijeet

Cancer Gene Therapy Market Type Analysis

Gene induced immunotherapy

Delivery of cytokine gene
Delivery of Tumor antigen gene

Oncolytic Virotherapy

Adenoviruses
Lentiviruses
Retrovirus
Adeno Associated Virus
Herpes Simplex Virus
Alphavirus
Vaccinia Virus
Simian Virus

Gene transfer / Gene replacement

Naked/Plasmid Vectors
Electroporation
Sonoporation
Magnetofection
Gene Gun

Report Content

Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Cancer Gene Therapy Industry Insights
Chapter 4. Cancer Gene Therapy Insights
Chapter 5. Cancer Gene Therapy Regional Insights
Chapter 6. Company Profiles
6.1. Sibiono Genetech
6.2. Shanghai Sunway Biotech Co., LTD
6.3. Human Stem Cell Institute
6.4. Altor Bioscience Corporation
6.5. Amgen
6.6. BioCancell
6.7. Aduro Biotech
6.8. OncoGeneX
6.9. Celsion
6.10. GlobeImmune, Inc
6.11. New Link Genetics
6.12. Immuno Frontier, Inc.
6.13. MolMed S.p.A
6.14. Advantagene
6.15. Sevion Therapeutics
6.16. ZioPharm Oncology
6.17. Gradalis
6.18. AstraZeneca
6.19. OncoSec Medical Incorporated
6.20. Jennerex Biotherapeutics, Inc.
6.21. Nova Rx Corporation

buying decision on this premium report https://www.marketstudyreport.com/enquiry-before-buying/467801?utm_source=openpr.com&utm_medium=Abhijeet

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.